Literature DB >> 65019

Cobalt-57-bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study.

J J Rasker, H Beekhuis, A M van de Wal, J N Homan van der Heide, M G Woldring.   

Abstract

Because the results with cobalt-57-bleomycin (57Co-bleo) as a tumour-seeking agent in patients with pulmonary tumours were promising, a prospective study was carried out to test the sensitivity and selectivity of this technique for metastases in lung hila and mediastinum in a group of patients with bronchial cancer. The sensitivity of 57Co-bleo scintigraphy appeared to be higher than that of routine radiological investigations and mediastinoscopy. For this reason it is suggested that 57Co-bleo scintigraphy can be used as a method to select patients for mediastinoscopy.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 65019      PMCID： PMC470488          DOI： 10.1136/thx.31.6.641

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  4 in total

1.  Comparison of 133Xenon regional studies during spontaneous breathing and bronchospirometry.

Authors:  R Peset; F Gimeno; J R van Haeringen; H Beekhuis; M G Woldring
Journal:  Scand J Respir Dis       Date:  1974

2.  Labelling of bleomycin with cobalt-57, indium-111, technetium-99m, mercury-197, lead-203, and copper-67.

Authors:  M A van de Poll; A Versluis; J J Rasker; H Jurjens; M G Woldring
Journal:  Nuklearmedizin       Date:  1976-04       Impact factor: 1.379

3.  Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.

Authors:  J J Rasker; A M Poll; H Beekhuis; M G Woldring; H O Nieweg
Journal:  J Nucl Med       Date:  1975-11       Impact factor: 10.057

4.  Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.

Authors:  R B Grove; R C Reba; W C Eckelman; M Goodyear
Journal:  J Nucl Med       Date:  1974-06       Impact factor: 10.057
  4 in total
  7 in total

Review 1.  Pre-operative mediastinal evaluation in primary bronchial carcinoma--a review of staging investigations.

Authors:  J A Elliott
Journal:  Postgrad Med J       Date:  1984-02       Impact factor: 2.401

2.  The influence of chemotherapy on the distribution of 57Co-bleomycin in chemically induced squamous cell carcinoma of mouse skin.

Authors:  T Pertynski; G Reznik; P Mariss; M B Ketkar; H Haindl; G Dieffenbach
Journal:  Eur J Nucl Med       Date:  1979-02-01

3.  Carbohydrate dependent targeting of cancer cells by bleomycin-microbubble conjugates.

Authors:  Jean-Charles Chapuis; Ryan M Schmaltz; Krystal S Tsosie; Marek Belohlavek; Sidney M Hecht
Journal:  J Am Chem Soc       Date:  2009-02-25       Impact factor: 15.419

4.  Detection of lung cancer with 55Co-bleomycin using a positron camera. A comparison with 57Co-bleomycin and 55Co-bleomycin single photon scintigraphy.

Authors:  O E Nieweg; H Beekhuis; A M Paans; D A Piers; W Vaalburg; J Welleweerd; T Wiegman; M G Woldring
Journal:  Eur J Nucl Med       Date:  1982

5.  57Co-bleomycin and 67Ga-citrate in detecting and staging lung cancer.

Authors:  O E Nieweg; H Beekhuis; D A Piers; H J Sluiter; A M van der Wal; M G Woldring
Journal:  Thorax       Date:  1983-01       Impact factor: 9.139

6.  Structural features facilitating tumor cell targeting and internalization by bleomycin and its disaccharide.

Authors:  Zhiqiang Yu; Rakesh Paul; Chandrabali Bhattacharya; Trevor C Bozeman; Michael J Rishel; Sidney M Hecht
Journal:  Biochemistry       Date:  2015-05-06       Impact factor: 3.162

7.  Modified bleomycin disaccharides exhibiting improved tumor cell targeting.

Authors:  Manikandadas M Madathil; Chandrabali Bhattacharya; Zhiqiang Yu; Rakesh Paul; Michael J Rishel; Sidney M Hecht
Journal:  Biochemistry       Date:  2014-10-22       Impact factor: 3.162
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.